These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24283410)

  • 1. Testosterone Treatment and Fractures in Men with Hypogonadism.
    Snyder PJ; Bauer DC; Ellenberg SS; Cauley JA; Buhr KA; Bhasin S; Miller MG; Khan NS; Li X; Nissen SE
    N Engl J Med; 2024 Jan; 390(3):203-211. PubMed ID: 38231621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Safety of Testosterone Dosage Forms.
    Layton JB; Meier CR; Sharpless JL; Stürmer T; Jick SS; Brookhart MA
    JAMA Intern Med; 2015 Jul; 175(7):1187-96. PubMed ID: 25962056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose ingestion does not lower testosterone concentrations in men on testosterone therapy.
    Dhindsa S; Ghanim H; McPhaul MJ; Ghoshal AK; Dandona P
    J Investig Med; 2024 Jun; 72(5):487-491. PubMed ID: 38644376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone levels increase following bariatric surgery - validation of preceding literature in a large-scale population analysis.
    Pozzi E; Able CA; Kohn TP; Salonia A; Ramasamy R
    Andrology; 2024 Jul; ():. PubMed ID: 38958350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, single-arm, 6-month trial of a wide-dose range oral testosterone undecanoate product.
    Bernstein JS; Dhingra OP
    Ther Adv Urol; 2024; 16():17562872241241864. PubMed ID: 38606384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.
    Steeves JA; Fitzhugh EC; Bradwin G; McGlynn KA; Platz EA; Joshu CE
    Andrology; 2016 May; 4(3):465-72. PubMed ID: 26991734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5-20% Topical Gels.
    Banov D; Biundo B; Ip K; Shan A; Banov F; Song G; Carvalho M
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in post-transplant serum testosterone levels in men undergoing lung transplantation: a pilot study using the TriNetX Research Network.
    Thompson A; Omil-Lima D; Perez JA; Jesse E; Khera M; Chavin K; Thirumavalavan N
    Int J Impot Res; 2024 Jun; ():. PubMed ID: 38839905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone concentrations and associated predictors in men with cystic fibrosis: a retrospective, single-center study.
    Jathal I; Wang Y; Binongo JNG; Cobb C; Hunt WR; Khan FN; Tangpricha V
    Am J Med Sci; 2024 Jul; ():. PubMed ID: 38997066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Incidence of Low Testosterone Levels in Young Male Adults with Moderate to Severe Obesity-Single-Centre Study from India.
    Shah SS; Kanani EAM; Kharat SK; Shah PS; Shah RM
    Obes Surg; 2024 Mar; 34(3):836-840. PubMed ID: 38282174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of testosterone.
    Hadgraft J; Lane ME
    Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.
    Finkle WD; Greenland S; Ridgeway GK; Adams JL; Frasco MA; Cook MB; Fraumeni JF; Hoover RN
    PLoS One; 2014; 9(1):e85805. PubMed ID: 24489673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
    Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting.
    Dobs AS; Campbell KJ
    Int J Gen Med; 2022; 15():7719-7733. PubMed ID: 36238539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations.
    Madsen MC; Heijer MD; Pees C; Biermasz NR; Bakker LEH
    Endocr Connect; 2022 Aug; 11(8):. PubMed ID: 35904217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring testosterone replacement therapy with transdermal gel: when and how?
    Sansone A; Sansone M; Selleri R; Schiavo A; Gianfrilli D; Pozza C; Zitzmann M; Lenzi A; Romanelli F
    J Endocrinol Invest; 2019 Dec; 42(12):1491-1496. PubMed ID: 31267510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone 2% gel can normalize testosterone concentrations in men with low testosterone regardless of body mass index.
    Dobs A; Norwood P; Potts S; Gould E; Chitra S
    J Sex Med; 2014 Mar; 11(3):857-64. PubMed ID: 24283410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel testosterone 2% gel for the treatment of hypogonadal males.
    Dobs AS; McGettigan J; Norwood P; Howell J; Waldie E; Chen Y
    J Androl; 2012; 33(4):601-7. PubMed ID: 21979302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men.
    Mazer N; Bell D; Wu J; Fischer J; Cosgrove M; Eilers B;
    J Sex Med; 2005 Mar; 2(2):213-26. PubMed ID: 16422889
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.